Asgard Therapeutics appoints Professor Dr Wolfram Brugger as Chief Medical Officer as it advances transformative 'personalized off-the-shelf' immunotherapy toward clinical ...

Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard's lead asset AT-108 into Phase 1 clinical development -- AT-108 is a transformative immunotherapy that ...

This method to reverse cellular aging is about to be tested in humans

Yuancheng Ryan Lu could barely breathe while he waited for his labmate to adjust the microscope focus. On the slide in front ...
Hosted on MSN

Programmable CRISPR cuts stem cell timing from months to weeks

On the one hand, more efficient reprogramming could, if poorly controlled, increase the chance of generating cells with unintended self renewal properties. On the other, precise control over gene ...
Kaleido Scope

Project 2: Redox Regulation of Metabolic Reprogramming in Activated Myofibroblasts

Project Leader: Victor Thannickal, M.D. Idiopathic pulmonary fibrosis (IPF) is chronic, progressive lung disorder with high mortality, and limited therapeutic options. Studies performed during Cycle I ...

Two La Jolla studies shed light on aging and the brain

Scientists at the Salk Institute for Biological Studies and Sanford Burnham Prebys explore genetic factors in separate papers ...
American Association for the Advancement of Science (AAAS)

Prize winner’s research reprograms tumor cells to trigger antitumor immunity

For his work towards developing a novel cancer immunotherapy that turns tumors into their own vaccines, Fábio Rosa has ...
Pharmabiz

Kazia Therapeutics expands oncology platform with first-in-class SETDB1 inhibitor drug development platform

Kazia Therapeutics expands oncology platform with first-in-class SETDB1 inhibitor drug development platform: Sydney, Australia Wednesday, April 15, 2026, 15:00 Hrs [IST] Kazia The ...
GEN

Genetic “Dimmer Switch” Offers Precise Gene Expression Control

Scientists at the MRC Laboratory of Medical Sciences (LMS) have discovered a DNA-based “dimmer switch” that regulates the activity of a critical developmental gene, Cdx2. This work could pave the way ...